A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

Scott, L., Soepenberg, O., Verweij, J., de Jonge, M.J.A., Planting, A.S.T., McGovern, D., Principe, P., Obach, R. and Twelves, C. (2007) A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours. Annals of Oncology, 18, pp. 569-575. (doi: 10.1093/annonc/mdl439)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Scott, Miss Lesley
Authors: Scott, L., Soepenberg, O., Verweij, J., de Jonge, M.J.A., Planting, A.S.T., McGovern, D., Principe, P., Obach, R., and Twelves, C.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Annals of Oncology

University Staff: Request a correction | Enlighten Editors: Update this record